PuSH - Publication Server of Helmholtz Zentrum München

Barthel, A.* ; Herzig, S.* ; Müller, H.W.* ; Harborth, J.* ; Bornstein, S.R.*

RNA interference-based strategies for metabolic syndrome treatment.

Horm. Metab. Res. 37, 59-62 (2005)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
RNA interference is a naturally occurring cellular mechanism to inhibit the expression of specific gene products. The technical application of RNA interference offers great potential for the specific treatment of a huge variety of diseases including the metabolic syndrome, one of the most challenging threats to human health associated with our civilization. In order to develop novel and powerful strategies for the treatment of the metabolic syndrome, it is essential to define a set of specific gene products that may be targeted by RNA interference. Based on currently available in vitro and in vivo data, we discuss the feasibility of candidate genes involved in the pathophysiology of the metabolic syndrome as potential targets for a rational RNA interference based therapy in this review.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2005
HGF-reported in Year 0
ISSN (print) / ISBN 0018-5043
e-ISSN 1439-4286
Quellenangaben Volume: 37, Issue: 2, Pages: 59-62 Article Number: , Supplement: ,
Publisher Thieme
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
PubMed ID 15778919
Erfassungsdatum 2005-12-31